These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21156883

  • 1. Clinical inertia in patients with T2DM requiring insulin in family practice.
    Harris SB, Kapor J, Lank CN, Willan AR, Houston T.
    Can Fam Physician; 2010 Dec; 56(12):e418-24. PubMed ID: 21156883
    [Abstract] [Full Text] [Related]

  • 2. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M, Benito-Badorrey B, Roura-Olmeda P, Franch-Nadal J, Pepió-Vilaubí JM, Saez M, Coll-de-Tuero G, GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine.
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [Abstract] [Full Text] [Related]

  • 3. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M, Yeaw J, Divino V, DeKoven M, Guerrero G, Langer J, Thorsted BL.
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [Abstract] [Full Text] [Related]

  • 4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N, Secnik K, Lage MJ.
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [Abstract] [Full Text] [Related]

  • 5. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK.
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [Abstract] [Full Text] [Related]

  • 6. Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.
    Harris S, Yale JF, Dempsey E, Gerstein H.
    Can Fam Physician; 2008 Apr; 54(4):550-8. PubMed ID: 18411384
    [Abstract] [Full Text] [Related]

  • 7. Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
    Yoon NM, Cavaghan MK, Brunelle RL, Roach P.
    Clin Ther; 2009 Jul; 31(7):1511-23. PubMed ID: 19695400
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M, Franch-Nadal J, Real J, Gratacòs M, López-Simarro F, Khunti K, Mauricio D.
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [Abstract] [Full Text] [Related]

  • 9. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P, Thomson A, Beynon J, Donegan K.
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [Abstract] [Full Text] [Related]

  • 10. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF, Arakaki R, Jiang H, Scism-Bacon J, Anderson PW, Fahrbach JL.
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [Abstract] [Full Text] [Related]

  • 11. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
    Polinski JM, Connolly JG, Curtis BH, Seeger JD, Gaskins K, Perez M, Smith BF, Shrank WH.
    Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
    [Abstract] [Full Text] [Related]

  • 12. Healthcare utilization changes in relation to treatment intensification with insulin aspart in patients with type 2 diabetes. Data from a large US managed-care organization.
    Aagren M, Luo W, Moës E.
    J Med Econ; 2010 Mar; 13(1):16-22. PubMed ID: 19958212
    [Abstract] [Full Text] [Related]

  • 13. Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
    Boye KS, Stein D, Matza LS, Jordan J, Yu R, Norrbacka K, Hassan SW, García-Pérez LE.
    Drugs R D; 2019 Jun; 19(2):213-225. PubMed ID: 31115873
    [Abstract] [Full Text] [Related]

  • 14. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J.
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [Abstract] [Full Text] [Related]

  • 15. Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial.
    Harris SB, Gerstein HC, Yale JF, Berard L, Stewart J, Webster-Bogaert S, Tompkins JW.
    BMC Health Serv Res; 2013 Feb 21; 13():71. PubMed ID: 23433347
    [Abstract] [Full Text] [Related]

  • 16. Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care.
    Bieszk N, Grabner M, Wei W, Barron J, Quimbo R, Yan T, Biel B, Chu JW.
    J Manag Care Spec Pharm; 2017 Nov 21; 23(11):1160-1168. PubMed ID: 29083969
    [Abstract] [Full Text] [Related]

  • 17. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
    Fu C, Ji L, Wang W, Luan R, Chen W, Zhan S, Xu B.
    J Endocrinol Invest; 2012 Mar 21; 35(3):269-73. PubMed ID: 21606668
    [Abstract] [Full Text] [Related]

  • 18. Current insulin therapy in patients with type 2 diabetes: results of the ADHOC survey in France.
    Penfornis A, San-Galli F, Cimino L, Huet D.
    Diabetes Metab; 2011 Nov 21; 37(5):440-5. PubMed ID: 21493117
    [Abstract] [Full Text] [Related]

  • 19. [Relationship between the degree of glycemic control and diabetes characteristics and hyperglycemia treatment in type 2 diabetes. DIABES Study].
    Pérez A, Franch J, Cases A, González Juanatey JR, Conthe P, Gimeno E, Matali A.
    Med Clin (Barc); 2012 May 05; 138(12):505-11. PubMed ID: 22118974
    [Abstract] [Full Text] [Related]

  • 20. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
    Manski-Nankervis JA, Furler J, O'Neal D, Ginnivan L, Thuraisingam S, Blackberry I.
    Prim Care Diabetes; 2017 Oct 05; 11(5):474-481. PubMed ID: 28705697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.